Henderson Molly's Form 4 filing
UroGen Pharma Ltd. (URGN) · filed Feb 2, 2022
- Accession no.
- 0001209191-22-006385
- Filed
- Feb 2, 2022
- Trade date
- Jan 31, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.51K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson MollyCIK 0001363812 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Ordinary Shares | MOption exerciseAcquired | +666 | –F1 | – | 5,579 | Direct | |
| Jan 31, 2022 | Ordinary Shares | SSaleDisposed | −331 | $7.58 | −$2,508.98 | 5,248 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Ordinary Shares | MOption exerciseDisposed | −1,334 | $0.00 | $0 | 1,334 | Direct | |
| Jan 31, 2022 | Ordinary Shares | AGrant or awardAcquired | +7,500 | $0.00 | $0 | 7,500 | Direct | |
| Jan 31, 2022 | Ordinary Shares | AGrant or awardAcquired | +30,000 | $0.00 | $0 | 30,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
Referenced by the price of 1 transaction in Table I.